David Shao is the founder of Yisheng Biopharma. Yisheng Biopharma has raised $170M in total funding. Latest round: Series B. Based in Beijing, China.
David Shao is the CEO of Yisheng Biopharma Co. Ltd., a Beijing-based biopharmaceutical company. He led the company as it advanced its recombinant protein COVID-19 vaccine candidate into clinical trials following a Series B financing round in March 2021.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide